» Articles » PMID: 15006599

Monoclonal Antibodies Produced by Muscle After Plasmid Injection and Electroporation

Overview
Journal Mol Ther
Publisher Cell Press
Date 2004 Mar 10
PMID 15006599
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Antibodies are useful for the treatment of a variety of diseases. We here demonstrate that mouse muscle produced monoclonal antibodies (mAb) after a single injection of immunoglobulin genes as plasmid DNA. In vivo electroporation of muscle greatly enhanced antibody production. For chimeric antibodies, levels of 50-200 ng mAb/ml serum were obtained but levels declined after 7-14 days due to an immune response against the xenogeneic parts of the antibody. By contrast, fully mouse antibodies persisted in serum for at least 7 months. mAb produced by the muscle had correct structure, specificity, and biological effector functions. The findings were extended to a larger animal, the sheep, in which mAb serum levels of 30-50 ng/ml were obtained. Sustained levels of serum mAb, induced by single injection of Ig genes and electroporation of muscle cells, may offer significant advantages in the treatment of human diseases.

Citing Articles

Expanding the Reach of Monoclonal Antibodies: A Review of Synthetic Nucleic Acid Delivery in Immunotherapy.

Chung C, Kudchodkar S, Chung C, Park Y, Xu Z, Pardi N Antibodies (Basel). 2023; 12(3).

PMID: 37489368 PMC: 10366852. DOI: 10.3390/antib12030046.


Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.

Hollevoet K, Thomas D, Compernolle G, Vermeire G, De Smidt E, De Vleeschauwer S Front Oncol. 2022; 12:1017612.

PMID: 36263202 PMC: 9574358. DOI: 10.3389/fonc.2022.1017612.


CORP: Gene delivery into murine skeletal muscle using in vivo electroporation.

Hughes D, Hardee J, Waddell D, Goodman C J Appl Physiol (1985). 2022; 133(1):41-59.

PMID: 35511722 PMC: 9236869. DOI: 10.1152/japplphysiol.00088.2022.


In Vivo Electroporation of Plasmid DNA: A Promising Strategy for Rapid, Inexpensive, and Flexible Delivery of Anti-Viral Monoclonal Antibodies.

Pagant S, Liberatore R Pharmaceutics. 2021; 13(11).

PMID: 34834297 PMC: 8618954. DOI: 10.3390/pharmaceutics13111882.


Immunotherapy perspectives in the new era of B-cell editing.

Ueda N, Cahen M, Danger Y, Moreaux J, Sirac C, Cogne M Blood Adv. 2021; 5(6):1770-1779.

PMID: 33755093 PMC: 7993091. DOI: 10.1182/bloodadvances.2020003792.